Key Points
- Paul Elliot Mann sold 50,000 shares of ASP Isotopes on Nov. 25 at an average price of $5.77 for $288,500, part of a recent string of large insider sales; he still holds 7,921,691 shares (a 0.63% reduction in his position).
- ASP Isotopes is trading near $6.20, below its 50‑day ($9.19) and 200‑day ($8.78) moving averages; the company reported an EPS loss of -$0.15 (miss) and deeply negative margins despite revenue beating estimates at $4.89M.
- Institutional ownership is notable (Vanguard recently boosted its stake), while analysts are mixed — one Buy and one Sell lead to a MarketBeat consensus of "Hold" with an average target of $13.
ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) insider Paul Elliot Mann sold 50,000 shares of the company's stock in a transaction dated Tuesday, November 25th. The stock was sold at an average price of $5.77, for a total transaction of $288,500.00. Following the transaction, the insider owned 7,921,691 shares of the company's stock, valued at $45,708,157.07. This represents a 0.63% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Paul Elliot Mann also recently made the following trade(s):
- On Monday, November 17th, Paul Elliot Mann sold 112,500 shares of ASP Isotopes stock. The shares were sold at an average price of $7.51, for a total transaction of $844,875.00.
- On Monday, September 8th, Paul Elliot Mann sold 81,076 shares of ASP Isotopes stock. The shares were sold at an average price of $8.53, for a total transaction of $691,578.28.
- On Tuesday, September 9th, Paul Elliot Mann sold 81,077 shares of ASP Isotopes stock. The stock was sold at an average price of $8.39, for a total transaction of $680,236.03.
ASP Isotopes Price Performance
Shares of NASDAQ:ASPI opened at $6.20 on Friday. The firm's 50 day moving average is $9.19 and its two-hundred day moving average is $8.78. The firm has a market capitalization of $687.10 million, a P/E ratio of -4.77 and a beta of 3.28. The company has a current ratio of 6.14, a quick ratio of 6.10 and a debt-to-equity ratio of 1.04. ASP Isotopes Inc. has a 52 week low of $3.65 and a 52 week high of $14.49.
ASP Isotopes (NASDAQ:ASPI - Get Free Report) last issued its quarterly earnings data on Wednesday, November 19th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.05). ASP Isotopes had a negative return on equity of 190.44% and a negative net margin of 1,259.12%.The business had revenue of $4.89 million for the quarter, compared to analyst estimates of $2.25 million. Analysts anticipate that ASP Isotopes Inc. will post -0.24 earnings per share for the current year.
Institutional Trading of ASP Isotopes
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in ASP Isotopes by 37.9% during the third quarter. Vanguard Group Inc. now owns 4,516,763 shares of the company's stock valued at $43,451,000 after buying an additional 1,241,024 shares in the last quarter. AWM Investment Company Inc. raised its position in ASP Isotopes by 6.2% in the first quarter. AWM Investment Company Inc. now owns 4,511,186 shares of the company's stock worth $21,157,000 after acquiring an additional 265,000 shares in the last quarter. Philadelphia Financial Management of San Francisco LLC lifted its holdings in ASP Isotopes by 11.2% in the 1st quarter. Philadelphia Financial Management of San Francisco LLC now owns 3,508,062 shares of the company's stock valued at $16,453,000 after acquiring an additional 354,517 shares during the last quarter. Rovida Investment Management Ltd lifted its holdings in ASP Isotopes by 45.5% in the 3rd quarter. Rovida Investment Management Ltd now owns 3,200,000 shares of the company's stock valued at $30,688,000 after acquiring an additional 1,000,000 shares during the last quarter. Finally, Rovida Advisors Inc. bought a new position in shares of ASP Isotopes during the 2nd quarter valued at about $16,148,000. Institutional investors own 16.80% of the company's stock.
Analysts Set New Price Targets
Several research analysts have recently issued reports on ASPI shares. Canaccord Genuity Group reissued a "buy" rating and issued a $11.00 price target on shares of ASP Isotopes in a research note on Monday, November 24th. Weiss Ratings restated a "sell (d-)" rating on shares of ASP Isotopes in a research note on Tuesday. Finally, Loop Capital set a $15.00 target price on shares of ASP Isotopes in a research report on Monday, October 27th. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $13.00.
Read Our Latest Research Report on ASPI
ASP Isotopes Company Profile
(
Get Free Report)
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
